Trial intelligence / Profile preview

Comparison of weight gain in premature neonates receiving 10% vs 12.5% dextrose intravenous solution

IRCT20200617047807N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
May 2020
Countries
1
01

Overview

Phase 3 trial of dextrose in low birth weight (LBW) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Weight gain. Started May 2020; status: completed.

02

Drugs

dextrose
03

Conditions

low birth weight (LBW)

Beyond the preview

Go deeper on IRCT20200617047807N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200617047807N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call